BRIEF published on 10/28/2026 at 11:11, 7 days 16 hours ago Défis et opportunités d'investissement en Allemagne Énergie Éolienne Données Industrielles Conditions D'investissement IA Allemande Investissement Chez Nvidia
BRIEF published on 10/28/2026 at 11:10, 7 days 16 hours ago DJI Launches Compact Power Auro 2000 Elite Compact Design DJI Power Auro 2000 Elite 2kWh Power Station Five Recharging Methods Durable And Portable
BRIEF published on 10/28/2026 at 11:10, 7 days 16 hours ago DJI lance l'Auro 2000 Elite, un générateur compact d'énergie Conception Compacte DJI Power Auro 2000 Elite Centrale Électrique De 2 KWh Cinq Méthodes De Recharge Durable Et Portable
BRIEF published on 10/28/2026 at 11:05, 7 days 16 hours ago FUCHS Expands African Presence with Strategic Investments Strategic Investments FUCHS Group Africa Expansion Sub-Saharan Africa Lubricants Industry
BRIEF published on 10/28/2026 at 11:05, 7 days 16 hours ago FUCHS renforce sa présence en Afrique grâce à des investissements stratégiques Investissements Stratégiques Expansion En Afrique Afrique Subsaharienne Industrie Des Lubrifiants Groupe FUCHS
BRIEF published on 10/28/2026 at 11:05, 7 days 16 hours ago DEBRA Research Invests in Topadur for New Therapies in Dystrophic Epidermolysis Bullosa DEBRA Research Topadur Pharma AG Dystrophic Epidermolysis Bullosa Small-Molecule Therapies TOP-N53
BRIEF published on 10/28/2026 at 11:05, 7 days 16 hours ago DEBRA Research investit dans Topadur pour de nouvelles thérapies contre l'épidermolyse bulleuse dystrophique Thérapies À Base De Petites Molécules Recherche DEBRA Topadur Pharma AG TOP-N53 Épidermolyse Bulleuse Dystrophique
BRIEF published on 10/28/2026 at 11:05, 7 days 16 hours ago DEBRA Research Supports Topadur in Developing Therapies for Dystrophic Epidermolysis Bullosa Epidermolysis Bullosa Thérapies DEBRA Research Topadur Pharma DualTOP® Platform
BRIEF published on 10/28/2026 at 11:05, 7 days 16 hours ago DEBRA Research soutient Topadur dans le développement de thérapies contre l'épidermolyse bulleuse dystrophique Epidermolyse Bulleuse Thérapies Recherche DEBRA Topadur Pharma Plateforme DualTOP®
BRIEF published on 10/28/2026 at 11:05, 7 days 16 hours ago Lancement de Q by EQS : Une IA pour la conformité EQS Group Automatisation Intelligence Artificielle Conformité Q By EQS
Published on 11/04/2026 at 23:10, 4 hours 51 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 1 minute ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 46 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 56 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:55, 6 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 51 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 3 hours 59 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 20 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours 36 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:00, 10 hours 1 minute ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 10 hours 1 minute ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 10 hours 17 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
